Ignite Creation Date:
2025-12-25 @ 2:16 AM
Ignite Modification Date:
2025-12-26 @ 12:46 AM
Study NCT ID:
NCT05349760
Status:
WITHDRAWN
Last Update Posted:
2023-01-19
First Post:
2022-03-31
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Phase 2 Study to Evaluate Safety and Efficacy of AMB-05X in Subjects With Idiopathic Pulmonary Fibrosis
Sponsor:
AmMax Bio, Inc.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-03
Start Date Type:
ESTIMATED
Primary Completion Date:
2025-03
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-31
First Submit QC Date:
None
Study First Post Date:
2022-04-27
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-01-17
Last Update Post Date:
2023-01-19
Last Update Post Date Type:
ACTUAL